SE7413858L - - Google Patents

Info

Publication number
SE7413858L
SE7413858L SE7413858A SE7413858A SE7413858L SE 7413858 L SE7413858 L SE 7413858L SE 7413858 A SE7413858 A SE 7413858A SE 7413858 A SE7413858 A SE 7413858A SE 7413858 L SE7413858 L SE 7413858L
Authority
SE
Sweden
Prior art keywords
formula
phenyl
sor1
so2r1
cardio
Prior art date
Application number
SE7413858A
Other languages
English (en)
Inventor
R Jonas
W Mehrof
K H Becker
H-J Schliep
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE7413858L publication Critical patent/SE7413858L/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7413858A 1973-11-07 1974-11-05 SE7413858L (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732355536 DE2355536A1 (de) 1973-11-07 1973-11-07 Adeninderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7413858L true SE7413858L (es) 1975-05-09

Family

ID=5897376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413858A SE7413858L (es) 1973-11-07 1974-11-05

Country Status (12)

Country Link
US (1) US3989833A (es)
JP (1) JPS5077395A (es)
BE (1) BE821893A (es)
DD (1) DD114414A5 (es)
DE (1) DE2355536A1 (es)
DK (1) DK133810C (es)
FR (1) FR2249672B1 (es)
GB (1) GB1444690A (es)
IL (1) IL45489A0 (es)
NL (1) NL7414527A (es)
SE (1) SE7413858L (es)
ZA (1) ZA745309B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
EP0457773A4 (en) * 1989-01-31 1993-03-10 Whitby Research Incorporated N?6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5670501A (en) * 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7203984A (es) * 1971-04-10 1972-10-12

Also Published As

Publication number Publication date
DD114414A5 (es) 1975-08-05
JPS5077395A (es) 1975-06-24
US3989833A (en) 1976-11-02
BE821893A (fr) 1975-05-06
DK133810B (da) 1976-07-26
FR2249672B1 (es) 1977-07-08
GB1444690A (en) 1976-08-04
NL7414527A (nl) 1975-05-12
AU7502574A (en) 1976-05-06
DK580074A (es) 1975-07-07
IL45489A0 (en) 1974-11-29
ZA745309B (en) 1975-09-24
DK133810C (da) 1976-12-13
FR2249672A1 (es) 1975-05-30
DE2355536A1 (de) 1975-05-22

Similar Documents

Publication Publication Date Title
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
AU537819B2 (en) 2-alkoxyphenyl-imidazo (4,5-b) pyridines
GB1441056A (en) Phenyl-pyridazines their preparation and use as herbicides
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
SE7413858L (es)
GB1069797A (en) ª‡-aminoketone derivatives
GB971245A (en) Method of preparation of heterocyclic compounds
ES478643A1 (es) Procedimiento de preparacion de nuevos derivados de la n-fe-nilalanina.
HUT35253A (en) Process for preparing 4-/3-alkynyl-oxy-2-hydroxy-propyl/-piperazin-1-y1-n-phenyl-acetamide derivatives
GB1096301A (en) 1,4-benzodioxane derivatives
ES437803A1 (es) Procedimiento para la preparacion de derivados de tiofeno.
ES475120A1 (es) Un procedimiento para la preparacion de imidazo (1,5-b)piri-dazinas.
ES419142A1 (es) Procedimiento para preparar derivados de tioseudourea.
ES437804A1 (es) Procedimiento para la preparacion de derivados de tiofeno.
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.
ES451375A1 (es) Procedimiento para la preparacion de 2-4 diamino-5-bencil-pirimidinas.
GB1499193A (en) Indolino-spiropyran compounds useful as colour formers
ES406768A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ZA80742B (en) Thiazole derivatives and their use in therapy
GB1378403A (en) Process for the preparation of 3-2h-isoquinolones
JPS57156440A (en) Novel derivatives of 4-methyl-3-formylpentanoic acid, manufacture and use for manufacturing cyclic derivatives
ES455539A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
ES445150A1 (es) Un procedimiento de preparacion de nuevos derivados tiazoli-cos.
ES412484A1 (es) Procedimiento para la preparacion de derivados carbostirili-cos.
ES435959A1 (es) Un procedimiento para obtener un derivado de pirido (3, 4-d)piridizina.